| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/08/2023 | 5.57% | Wedbush | → $5.5 | Reiterates | → Neutral |
| 05/04/2023 | -4.03% | Barclays | $6 → $5 | Maintains | Equal-Weight |
| 04/28/2023 | 5.57% | Citigroup | $7 → $5.5 | Maintains | Neutral |
| 03/29/2023 | -4.03% | UBS | $7 → $5 | Maintains | Neutral |
| 02/03/2023 | 15.16% | Credit Suisse | $7 → $6 | Maintains | Neutral |
| 02/03/2023 | 34.36% | Citigroup | $8 → $7 | Maintains | Neutral |
| 01/13/2023 | 53.55% | Barclays | $7 → $8 | Maintains | Equal-Weight |
| 11/10/2022 | 34.36% | Credit Suisse | $10 → $7 | Downgrades | Outperform → Neutral |
| 11/07/2022 | 34.36% | Citigroup | $11 → $7 | Maintains | Neutral |
| 10/31/2022 | -4.03% | Wells Fargo | $13 → $5 | Downgrades | Overweight → Underweight |
| 08/15/2022 | 111.13% | Barclays | $13 → $11 | Maintains | Equal-Weight |
| 08/12/2022 | 168.71% | B. Riley Securities | $18 → $14 | Maintains | Buy |
| 08/12/2022 | 149.52% | Credit Suisse | $15 → $13 | Maintains | Outperform |
| 07/13/2022 | 130.33% | Evercore ISI Group | $18 → $12 | Downgrades | Outperform → In-Line |
| 07/07/2022 | 149.52% | Wells Fargo | $18 → $13 | Maintains | Overweight |
| 06/09/2022 | 149.52% | Barclays | $18 → $13 | Downgrades | Overweight → Equal-Weight |
| 06/08/2022 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 05/18/2022 | 111.13% | Stifel | $13 → $11 | Maintains | Hold |
| 05/10/2022 | 245.49% | Barclays | $20 → $18 | Maintains | Overweight |
| 05/06/2022 | 264.68% | Credit Suisse | $23 → $19 | Maintains | Outperform |
| 05/06/2022 | 168.71% | Citigroup | $17 → $14 | Maintains | Neutral |
| 05/06/2022 | 149.52% | Stifel | $26 → $13 | Downgrades | Buy → Hold |
| 04/05/2022 | 245.49% | Wells Fargo | $20 → $18 | Maintains | Overweight |
| 02/04/2022 | 341.46% | Credit Suisse | $26 → $23 | Maintains | Outperform |
| 10/15/2021 | 322.26% | Wells Fargo | $24 → $22 | Maintains | Overweight |
| 10/05/2021 | 245.49% | Wedbush | → $18 | Initiates Coverage On | → Neutral |
| 08/06/2021 | 399.04% | Barclays | $23 → $26 | Maintains | Overweight |
| 07/13/2021 | 341.46% | Wells Fargo | → $23 | Upgrades | Equal-Weight → Overweight |
| 05/12/2021 | 379.85% | Stifel | $18 → $25 | Upgrades | Hold → Buy |
| 05/12/2021 | 283.88% | Wells Fargo | → $20 | Upgrades | Underweight → Equal-Weight |
| 02/10/2021 | 322.26% | Credit Suisse | $18 → $22 | Maintains | Outperform |
| 12/14/2020 | 187.91% | Stifel | $17 → $15 | Downgrades | Buy → Hold |
| 11/06/2020 | 207.1% | Raymond James | $20 → $16 | Maintains | Strong Buy |
| 07/15/2020 | 168.71% | B of A Securities | $8.5 → $14 | Upgrades | Underperform → Neutral |
| 07/15/2020 | 283.88% | Raymond James | → $20 | Upgrades | Market Perform → Strong Buy |
| 07/14/2020 | 187.91% | Credit Suisse | $13 → $15 | Upgrades | Neutral → Outperform |
| 05/04/2020 | 82.34% | UBS | $9 → $9.5 | Maintains | Neutral |
| 04/30/2020 | 53.55% | CFRA | $12 → $8 | Maintains | Sell |
| 04/24/2020 | 72.74% | Deutsche Bank | $15 → $9 | Maintains | Hold |
| 04/15/2020 | 72.74% | UBS | $14.8 → $9 | Maintains | Neutral |
| 04/01/2020 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 03/26/2020 | 168.71% | B. Riley Securities | $22 → $14 | Maintains | Buy |
| 03/16/2020 | 53.55% | Wells Fargo | $12 → $8 | Maintains | Underweight |
| 02/10/2020 | 322.26% | B. Riley Securities | $26 → $22 | Reiterates | → Buy |
| 01/02/2020 | 130.33% | Wells Fargo | → $12 | Downgrades | Equal-Weight → Underweight |
| 12/13/2019 | 149.52% | B of A Securities | $16 → $13 | Downgrades | Neutral → Underperform |
| 11/13/2019 | 207.1% | Barclays | → $16 | Initiates Coverage On | → Equal-Weight |
| 09/06/2019 | 187.91% | UBS | $16 → $15 | Maintains | Neutral |
| 08/02/2019 | 207.1% | Citigroup | $19 → $16 | Maintains | Neutral |
| 08/02/2019 | 226.3% | B of A Securities | $20 → $17 | Reiterates | → Neutral |
| 01/11/2019 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 01/02/2019 | 168.71% | Wells Fargo | $18 → $14 | Maintains | Market Perform |
| 12/03/2018 | 245.49% | Citigroup | $17 → $18 | Maintains | Neutral |
| 11/02/2018 | 245.49% | B of A Securities | $20 → $18 | Maintains | Neutral |
| 11/02/2018 | 245.49% | Barclays | $19 → $18 | Maintains | Equal-Weight |
| 11/02/2018 | 226.3% | Nomura | $18 → $17 | Maintains | Neutral |
| 10/23/2018 | 283.88% | Standpoint Research | → $20 | Initiates Coverage On | → Buy |
| 10/17/2018 | 360.65% | Buckingham Research | $26 → $24 | Maintains | Buy |
| 08/23/2018 | 168.71% | Macquarie | $15 → $14 | Maintains | Neutral |
| 08/16/2018 | 399.04% | Buckingham Research | $28 → $26 | Maintains | Buy |
What is the target price for Hanesbrands (HBI)?
The latest price target for Hanesbrands (NYSE: HBI) was reported by Wedbush on August 8, 2023. The analyst firm set a price target for $5.50 expecting HBI to rise to within 12 months (a possible 5.57% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hanesbrands (HBI)?
The latest analyst rating for Hanesbrands (NYSE: HBI) was provided by Wedbush, and Hanesbrands reiterated their neutral rating.
When is the next analyst rating going to be posted or updated for Hanesbrands (HBI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hanesbrands, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hanesbrands was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.
Is the Analyst Rating Hanesbrands (HBI) correct?
While ratings are subjective and will change, the latest Hanesbrands (HBI) rating was a reiterated with a price target of $0.00 to $5.50. The current price Hanesbrands (HBI) is trading at is $5.21, which is within the analyst's predicted range.